Transcription of MATERIAL SAFETY DATA SHEET - Pfizer
{{id}} {{{paragraph}}}
1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKINGM aterial Name: Spironolactone and Hydrochlorothiazide TabletsTrade Name:AldactazideChemical Family:MixtureIntended Use:Pharmaceutical product used as antihypertensive, diuretic2. HAZARDS IDENTIFICATIONA ppearance:Tan film-coated tabletsSignal Word:DANGERS tatement of Hazard:May damage fertility or the unborn of causing cause damage to: blood and blood forming organs through prolonged or Hazard Information:Short Term:Antihypertensive drug: has blood pressure-lowering propertiesLong Term:Repeat-dose studies in animals have shown a potential to cause adverse effects on blood,kidneys, reproductive Clinical Effects:Signs and symptoms might include nausea, vomiting, cramps, dizziness, headache, vertigo,low blood pressure on standing, rash, urticaria, photosensitivity, electrolyte imbalance, musclespasm, weakness, and restlessness. Hypersensitivity reactions may also occur in susceptibleindividuals.
MATERIAL SAFETY DATA SHEET _____ Symptoms and Effects of Exposure: For information on potential signs and symptoms of exposure, See Section 2 - Hazards Identification and/or Section 11 - Toxicological Information.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Prolonged-release film-coated tablets, Mg Prolonged-release Tablets PL, MG PROLONGED-RELEASE TABLETS, PL 27900, MG PROLONGED-RELEASE TABLETS PL 27900, UK Public Assessment Report, Prolonged release tablets, Prolonged release, DATA SHEET DILZEM, DATA SHEET . DILZEM, Tablets, Film, Coated, Metformin, Release, Release tablets, REVISION OF MONOGRAPH ON TABLETS, World, MOTILIUM 10 mg Tablets, Panadol, NEW ZEALAND DATA SHEET NAME OF MEDICINE